BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1995 related articles for article (PubMed ID: 25194181)

  • 1. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nonalcoholic fatty liver disease].
    Lemoine M; Serfaty L
    Presse Med; 2012 Feb; 41(2):169-89. PubMed ID: 21723084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonalcoholic fatty liver disease].
    Ko JS
    Korean J Gastroenterol; 2010 Jul; 56(1):6-14. PubMed ID: 20664312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.
    Kim CH; Younossi ZM
    Cleve Clin J Med; 2008 Oct; 75(10):721-8. PubMed ID: 18939388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future therapeutic strategies in NAFLD.
    Mark N; de Alwis W; Day CP
    Curr Pharm Des; 2010 Jun; 16(17):1958-62. PubMed ID: 20370671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
    Moore JB
    Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease: A sign of systemic disease.
    Reccia I; Kumar J; Akladios C; Virdis F; Pai M; Habib N; Spalding D
    Metabolism; 2017 Jul; 72():94-108. PubMed ID: 28641788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Brown GT; Kleiner DE
    Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease in lean individuals in the United States.
    Younossi ZM; Stepanova M; Negro F; Hallaji S; Younossi Y; Lam B; Srishord M
    Medicine (Baltimore); 2012 Nov; 91(6):319-327. PubMed ID: 23117851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in nonalcoholic fatty liver disease.
    Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
    Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kramer JA; Grindley J; Crowell AM; Makaron L; Kohli R; Kirby M; Mansfield KG; Wachtman LM
    Vet Pathol; 2015 Mar; 52(2):404-13. PubMed ID: 24913270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic fatty liver diseases: hepatic consequences of the metabolic syndrome].
    Anty R; Gual P; Huet PM; Marchand-Brustel YL; Tran A
    Gastroenterol Clin Biol; 2007 Dec; 31(12):1127-34. PubMed ID: 18176372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; MiezyƄska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
    Bosserhoff A; Hellerbrand C
    Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 100.